Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Masuko

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Nature Communications|June 8, 2012
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cellToshifumi Yae, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Cancer Science|November 19, 2020
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 geneKouki Okita, Yuta Hara, Hiroshi Okura, et al.
Cancer Cell|March 15, 2011
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthTakatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, et al.
Cancer Research|March 17, 2016
The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)Kenji Tsuchihashi, Shogo Okazaki, Mitsuyo Ohmura, et al.
Plos One|January 25, 2012
Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cellsKazue Masuko, Shogo Okazaki, Mayumi Satoh, et al.
Science Translational Medicine|February 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chainKana Hasegawa, Shunya Ikeda, Moto Yaga, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Nature Communications|June 8, 2012
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cellToshifumi Yae, Kenji Tsuchihashi, Takatsugu Ishimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Cancer Science|November 19, 2020
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 geneKouki Okita, Yuta Hara, Hiroshi Okura, et al.
Cancer Cell|March 15, 2011
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growthTakatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, et al.
Cancer Research|March 17, 2016
The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)Kenji Tsuchihashi, Shogo Okazaki, Mitsuyo Ohmura, et al.
Plos One|January 25, 2012
Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cellsKazue Masuko, Shogo Okazaki, Mayumi Satoh, et al.
Science Translational Medicine|February 16, 2022
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chainKana Hasegawa, Shunya Ikeda, Moto Yaga, et al.
Pageof 9